Shim system for removing ICD artifacts from patient cardiac MR images

Ended Project Grant Awarded Last action

Award ID
R41HL166053
Recipient
Awarding agency
Obligated
$619,884

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Description

Abstract
1.4 million people in the US (2021) have implanted cardioverter-defibrillators (icds) of which ~50% will require an MRI scan in their lifetime. All icds generate large artifacts in MRI such as signal-voids in cardiac MR (CMR) images, which frequently occur in important pathological (infarcted) regions. Reliable diagnosis of ventricular tachycardia, premature ventricular contraction and myocarditis using CMR is therefore prevented, as well as MR-guided therapy of these potentially life-threatening diseases. The scanner's own shim coils cannot correct these large inhomogeneities, so powerful dedicated resistive shim coils are required. IT is proposed that a cardiac shim system (CSS), consisting of a mechanical frame for accurate shim-coil placement, a shim coil, a programmable power supply, electromagnetic filtering circuits, shim-coil placement optimization software, and system-use protocols can be used to precisely reduce artifacts in a user-determined region of the heart. The innovative CSS design does not interact with, and is not acted upon by, the RF coils and the gradient coils of the scanner, maintaining the scanner's specified performance. Furthermore, the magnetic forces acting upon the CSS are balanced, permitting the shim coil to be moved freely within the MRI scanner bore and maximizing patient safety. Aim 1 of this phase i sttr project is to develop a commercial prototype (V2), based upon the initial proof- of-concept system (V1), to be used on a siemens 1.5T MRI scanner at JHU. This includes refinements in shim coil design, software reconstruction, protocol development, and the development of a motorized positioning system. In aim 2, IT is proposed, to test this novel system quantitatively using 5 infarcted swine and 6 human volunteers to demonstrate CSS effectiveness in performing CMR safely using standard cardiac MRI protocols such as LGE and cine. Future phase 2 efforts will pursue clinical testing to prepare for submission to the FDA for regulatory clearance.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $309,942
Original award $309,942

Quick answers

Who received award R41HL166053?

R41HL166053 was awarded to Mirtech Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 15, 2022.

How much is award R41HL166053 worth?

$619,884 has been obligated on R41HL166053.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award